Michael D. Rogers, Chief Development Officer at Pharmasset Inc (VRUS), sold 13,771 shares at $18.13 ($251K) on 2008-11-13, disclosed to the SEC on 2008-11-17.
Scheduled sale ($251k) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 2,500 | $45K | 17.9% |
| 2 | $18.02 | 400 | $7K | 2.9% |
| 3 | $18.05 | 400 | $7K | 2.9% |
| 4 | $18.07 | 400 | $7K | 2.9% |
| 5 | $18.08 | 200 | $4K | 1.4% |
| 6 | $18.10 | 100 |
| $2K |
| 0.7% |
| 7 | $18.12 | 1,080 | $20K | 7.8% |
| 8 | $18.13 | 200 | $4K | 1.4% |
| 9 | $18.14 | 600 | $11K | 4.3% |
| 10 | $18.20 | 120 | $2K | 0.9% |
| 11 | $18.21 | 600 | $11K | 4.4% |
| 12 | $18.23 | 100 | $2K | 0.7% |
| 13 | $18.24 | 600 | $11K | 4.4% |
| 14 | $18.25 | 1,672 | $31K | 12.2% |
| 15 | $18.26 | 400 | $7K | 2.9% |
| 16 | $18.27 | 400 | $7K | 2.9% |
| 17 | $18.29 | 300 | $5K | 2.2% |
| 18 | $18.32 | 400 | $7K | 2.9% |
| 19 | $18.35 | 1,430 | $26K | 10.5% |
| 20 | $18.37 | 100 | $2K | 0.7% |
| 21 | $18.38 | 100 | $2K | 0.7% |
| 22 | $18.39 | 70 | $1K | 0.5% |
| 23 | $18.40 | 300 | $6K | 2.2% |
| 24 | $18.43 | 300 | $6K | 2.2% |
| 25 | $18.50 | 600 | $11K | 4.4% |
| 26 | $18.55 | 99 | $2K | 0.7% |
| 27 | $18.58 | 200 | $4K | 1.5% |
| 28 | $18.59 | 100 | $2K | 0.7% |
| Total | $18.21 avg | 13,771 | $251K | 100% |
| Filing → |
| VRUS | SELL | 2008-11-17 | $54K | — | Filing → |
| VRUS | SELL | 2008-11-05 | $38K | — | Filing → |